INSERM, U991, Université de Rennes 1, F-35000 Rennes, France.
J Anal Toxicol. 2013 Mar;37(2):110-6. doi: 10.1093/jat/bks139. Epub 2013 Jan 12.
A fast and sensitive liquid chromatography-tandem mass spectrometry (LC-MS-MS) method was developed and validated for the simultaneous determination of acetaminophen (APAP) and its glucuronide and sulfate metabolites (APAP-GLU and APAP-SUL) in small plasma volumes. This method included a simple step of sample preparation and a chromatographic separation on an LC-MS-MS system equipped with an electrospray ionization source and a tandem triple quadrupole mass spectrometer in multiple reaction monitoring mode. The analytes and internal standard, APAP deuterated analog, were separated on a C18 column (3.0 µm, 2.1 × 100 mm), using aqueous 1% formic acid and methanol (80:20, v/v) as the mobile phase. The LC-MS-MS method was validated for accuracy, precision, linearity, extraction efficiency, process efficiency and matrix effect. Calibration curves were obtained by fortifying drug-free plasma and ranges of linearity were set between 0.25-20 mg/L. The mean correlation coefficients, r², were >0.99 for APAP and its metabolites. The inter-day and intra-day precision values were less than 11.75 and 13.03%, respectively, at the lower limit of quantification concentration. The usability of the method was demonstrated by studying APAP metabolism in C57BL/6J wild-type and obese ob/ob female mice, in which only small plasma volumes were available. The results showed that APAP glucuronidation was enhanced in obese mice, suggesting that changes in APAP metabolism could modify its toxicity in obesity and related fatty liver disease.
建立并验证了一种灵敏、快速的液相色谱-串联质谱(LC-MS-MS)法,用于同时测定小体积血浆中的醋氨酚(APAP)及其葡萄糖醛酸和硫酸盐代谢物(APAP-GLU 和 APAP-SUL)。该方法包括样品制备的简单步骤和 LC-MS-MS 系统上的色谱分离,该系统配备电喷雾源和串联三重四极杆质谱仪,采用多反应监测模式。分析物和内标物(APAP 氘代类似物)在 C18 柱(3.0 µm,2.1×100 mm)上分离,以水相 1%甲酸和甲醇(80:20,v/v)为流动相。该 LC-MS-MS 方法经过准确度、精密度、线性、提取效率、过程效率和基质效应的验证。通过对无药物血浆进行加标来获得校准曲线,线性范围设定在 0.25-20 mg/L。APAP 及其代谢物的平均相关系数 r²均>0.99。在定量下限浓度下,日间和日内精密度值分别小于 11.75%和 13.03%。该方法的可用性通过研究 C57BL/6J 野生型和肥胖 ob/ob 雌性小鼠中的 APAP 代谢得到了证明,其中只有小体积的血浆可用。结果表明,肥胖小鼠中 APAP 葡萄糖醛酸化增强,提示 APAP 代谢的变化可能会改变肥胖及其相关脂肪肝疾病中的毒性。